ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

Senate Confirms McClellan For FDA

October 25, 2002

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990

Lame-Duck Session Required To Complete HHS Funding Bill; Nobel Laureates For Gore.

November 10, 2000